Dyadic International, Inc. (NASDAQ: DYAI)

We are a global biotechnology company committed to building disruptive microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical products for human and animal health.

With a passion to enable our partners and collaborators to develop effective preventative and therapeutic treatments in both developed and emerging countries, Dyadic is building an active pipeline by advancing its proprietary filamentous fungal based

At Dyadic, we are passionate to enable our partners and collaborators to develop effective protein production and biologic products for human and animal health.

We actively pursue product and program development, licensing and co-development opportunities that are aligned our areas of expertise with our partners needs and offer significant value to our pipeline.


The future of meat starts hereDyadic has recently entered into a co-marketing partnership with Biftek, Inc. This partnership aims to promote Biftek’s patent-pending high performing, animal-free growth medium supplement, designed to reduce the costs associated with expensive culture media components such as fibroblast growth factor. Please reach out to us to learn more about this exciting growth medium supplement as well as Dyadic’s other alternative proteins and enzymes.